Science moves faster when the pathway is clear.

BioCellR8 connects scientific strategy, clinical execution, regulatory pathways, and operational infrastructure—aligning expertise and resources to move ideas into impact.

Scientific visualization of connected mammalian cells

Coordinated translational support from strategy to impact.

We partner with biotech, medtech, pharmaceutical, clinical-research, and regulatory organizations to clarify complex pathways, coordinate specialized expertise, and keep programs moving toward meaningful milestones.

Integrated expertise

Scientific, clinical, regulatory, and operational perspectives work in concert—reducing gaps between strategy and execution.

Clear pathways

We identify requirements, dependencies, and decisions early so programs can advance with greater confidence.

Operational discipline

Practical governance, documentation, and program controls turn complex initiatives into manageable work.

Trusted partnership

Our work is tailored to the client’s science, assets, resources, risk profile, and definition of success.

Capabilities built around the path to translation.

Focused support can begin at a single milestone or extend across a coordinated program.

01

Lab Space & Bioacceleration

We identify laboratory environments suited to a client’s technical and operating needs, then support evaluation, agreements, permitting, readiness planning, vendor coordination, and the practical steps required to begin work.

02

Clinical Trial Services

End-to-end clinical development support spanning study design, protocol and site strategy, regulatory coordination, recruitment planning, trial oversight, data-management coordination, quality controls, and closeout.

03

Regulatory Affairs Consulting

Strategic pathway assessment, submission planning and support, clinical and technical documentation, agency-interaction preparation, compliance programs, and post-approval commitments for regulated life-science ventures.

04

Operational Excellence

Operating-model design, program management, process improvement, quality-system support, resource planning, governance, and data-informed controls that help teams execute consistently and scale responsibly.

05

Strategic Advisory & Growth

Portfolio and program strategy, organizational planning, partnership development, commercialization readiness, funding support, and executive guidance shaped around the next critical business milestone.

A disciplined path to meaningful outcomes.

  1. 1

    Align

    Define goals, evidence, constraints, stakeholders, risks, and the measures of success.

  2. 2

    Design

    Build a tailored scientific, clinical, regulatory, and operating plan with clear ownership.

  3. 3

    Navigate

    Coordinate execution, submissions, partners, decisions, and emerging risks with rigor.

  4. 4

    Accelerate

    Remove barriers, measure progress, and prepare the organization for its next milestone.

Experience across science, medicine, compliance, and enterprise.

Robert L. Zailckas

Robert L. Zailckas

Founder & Principal

Robert brings more than three decades of international executive, operational, program-management, and entrepreneurial experience. His work spans bioscience, healthcare, aviation, technology, and regulated programs, with current advisory work supporting drug-delivery, medical-device, and emerging biomedical ventures.

Anthony R. Ball

Anthony R. Ball

Vice President of Global Compliance

Anthony supports the integration of compliance requirements into practical global operating strategies. His focus is helping organizations translate policy, documentation, governance, and regulatory expectations into clear, durable systems for execution.

George P. Tegos, PhD

George P. Tegos, PhD

Director of Translational Sciences

George is a translational scientist whose published research includes antimicrobial resistance, anti-infective discovery, photomedicine, and multidrug-resistance mechanisms. He helps connect discovery science with development strategy and real-world translational pathways.

Mark Martins, MD, FACOG

Mark Martins, MD, FACOG

Medical Director

Dr. Martins is an obstetrician-gynecologist and Fellow of the American College of Obstetricians and Gynecologists. He brings clinical perspective to study design, medical oversight, patient-centered planning, and the evaluation of translational opportunities in women’s health.

Bring the next milestone into focus.

We welcome confidential introductory conversations about scientific programs, clinical development, regulatory pathways, operational needs, and strategic collaboration.

82 Park Road
Charlton, Massachusetts 01507
(617) 513-7046 rzailckas@biocellr8.com

Submitting opens a prepared email in your default email application. No information is stored by this website.